Company Analysis

ImmunityBio, Inc. (IBRX)

Nasdaq: IBRX · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2005
Grade5.5
◀ Past 5.2● Present 5.1▶ Future 6.2
1 est.

Who runs ImmunityBio, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Adcock Richard
CEO & President. First filing Oct 2020, latest Feb 24, 2026, 1 filing in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
19 people on the record since 2015
Officerssales are open-market, Oct 6, 2025 to Oct 6, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Simon Barry J.President and Chief Administrative OfficerJul 2015Oct 6, 20268 · $4.4M
Soon-Shiong PatrickFounder, Executive Chairman, Global Chief Scientific and Medical OfficerJul 2015Apr 2, 2026none
Adcock RichardCEO & PresidentOct 2020Feb 24, 2026none
Sachs David C.Chief Financial OfficerMar 2021Feb 24, 2026none
Lauer Regan JChief Accounting OfficerNov 2021Feb 24, 2026none
Directorssales are open-market, Oct 6, 2025 to Oct 6, 2026
NameRoleFirst filingLatest filingSales, 12 months
Cohen CheryldirectorJun 2019Oct 6, 20262 · $2.1M
Selecky ChristobeldirectorMar 2021Jul 6, 20266 · $3.0M
Blaszyk Michael DdirectorAug 2015Jun 10, 2026none
Clark WesleydirectorMar 2021Jun 10, 2026none
Maxwell LindadirectorApr 2021Jun 10, 2026none
Wendel BrucedirectorDec 2025Jun 10, 2026none
Owners of more than 10% of a classsales are open-market, Oct 6, 2025 to Oct 6, 2026
NameRoleFirst filingLatest filingSales, 12 months
California Capital Equity, LLC10% ownerDec 2022Apr 2, 2026none
Cambridge Equities, LP10% ownerJul 2015Apr 2, 2026none
Mp 13 Ventures, LLC10% ownerJul 2015Apr 2, 2026none
Nant Capital, LLC10% ownerSep 2023Apr 2, 2026none
Earlier names on the record9, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton IBRX · research, not advice